Disclosure of PHI to DoD Safety Offices
This HIPAA Information Paper describes the Disclosure of PHI to DoD Safety Offices (updated February 2012).
This website has recently undergone changes. Users finding unexpected concerns may care to clear their browser's cache to ensure a seamless experience.
Learn more about the Freedom of Information Act (FOIA) Reading Room, which is part of the 1996 amendments to FOIA, mandating publicly accessible "electronic reading rooms" with agency FOIA response materials and other information routinely available to the public.
Please note that files more than five years old may not be compliant with Section 508 of the Rehabilitation Act. If you need an accessible version of a particular file, please contact us and we will provide one for you.
We found 715 items
This HIPAA Information Paper describes the Disclosure of PHI to DoD Safety Offices (updated February 2012).
This HIPAA Information Paper describes the Health Information Technology (HIT) Initiatives.
This HIPAA Information Paper provides details on Obtaining Military Records (update May 2010).
This HIPAA Information Paper describes the Special Rules for Alcohol and Drug Abuse Program Patient Records (updated September 2011).
This HIPAA Information Paper describes the Uses and Disclosures When an Authorization is Required.
This HIPAA Information Paper describes Medical Training and Education (updated January 2012).
This HIPAA Information Paper describes Encryption of E-Mail (updated September 2012).
This HIPAA Information Paper describes Security Incident Procedures (updated September 2012).
This HIPAA Information Paper describes the Decedents: Use and Disclosure (updated February 2012).
This document summarizes decisions regarding Inhaled Corticosteroids on the TRICARE formulary
This document summarizes the decisions regarding Inhaled Nasal Allergy Drugs on the TRICARE Formulary
This document summarizes decisions regarding Oral Bosphosphonates on the TRICARE formulary
This documents outlines the roles and responsibilities of the applicant/recipient as part of a Data Sharing Agreement (DSA).
This documents outlines the roles and responsibilities of the government sponsor as part of a Data Sharing Agreement (DSA).
This document summarizes the decisions regarding Inhaled Corticosteroids/Long-Acting Beta Agonists (ICS/LABAs) on the TRICARE Formulary
The appearance of hyperlinks does not constitute endorsement by the Department of Defense of non-U.S. Government sites or the information, products, or services contained therein. Although the Defense Health Agency may or may not use these sites as additional distribution channels for Department of Defense information, it does not exercise editorial control over all of the information that you may find at these locations. Such links are provided consistent with the stated purpose of this website.
You are leaving Health.mil View the external links disclaimer.